May 1st 2025
The Zensights Federated Healthcare Advisory Panel explores how shifting global dynamics are reshaping access and strategic planning across the healthcare system.
April 30th 2025
A panel of experts examines how stakeholders can support strategies that improve patient outcomes, while also navigating various distribution models.
April 29th 2025
IQVIA’s Doug Long offers a lay of the land, including trends and developing issues that are shaping the current market.
April 28th 2025
The company’s branded form of nadofaragene firadenovec-vncg will also be produced at a hub in Parsippany, NJ.
April 23rd 2025
The program measures a company’s air cargo supply chain efforts when it comes to quality, safety, and compliance.
Pre-approval access and real-world evidence: a win-win proposition
Bridging gaps in communicating with patients
Accenture survey focuses on healthcare providers’ experiences
Pharmaceutical Cargo Security Coalition becomes an arm of HDA
Details on transition will be forthcoming
HDA survey finds serialization readiness is crawling along
Equipment availability is cited as a cause for delay
McKesson grabs up RxCrossroads, US hub services provider to pharma
$735-million acquisition adds to McKesson Specialty Health
Bye-bye QuintilesIMS; hello IQVIA
New identity stresses ‘human data science’
Veeva offers a comprehensive data repository of oncologists
Oncology Link brings identifications, affiliations and activities of oncologists together globally
DHL Global Forwarding expands operations in Boston
The station is part of a strategic US growth plan
Elpro offers a unit-dose-level temperature indicator for last-mile tracking
Libero ITS provides both indication and datalogging
Investigative report slams drug distributors over opioid-abuse epidemic
Intent of the 2016 Ensuring Patient Access and Effective Drug Enforcement Act is questioned
Open-SCS group announces a new serialization standard
Intent is to streamline data communications within an enterprise
What you’re not hearing about Hurricanes Harvey and Irma
Pharma supply chain participants are coordinating their response
The power of strategic data standardization
Global efforts to collect clinical data in a more standardized form will lead to more research innovation
2017 Cold Chain Outlook
“Cold chain” now means cryogenic and ambient shipping, as well as the traditional 2–8° range
LogiPharma meeting highlights digital transformation
Supply chain leaders gather in Philadelphia in October
Drug development in rare diseases
HDA’s fourth international conference heads to Geneva
Global supply chain issues in distribution bring senior execs together
GE Healthcare offers an automated device for cell thawing
A better way to reverse the cryopreservation common in cellular therapies
PCI adds to cold chain capacity in Philadelphia
A 60% increase in pallet storage capability
FDA approves Novartis’ CAR-T therapy for leukemia, ushering in the gene therapy era
First gene therapy product in US; approval expedited by evidence of high cure rates
Gilead-Kite Pharma deal reverberates through cell-therapy field
Investors hope for a repeat of Gilead’s Sovaldi success
ODA-designation application to approval in 19 days for Curtana Pharmaceuticals
Company is targeting a treatment for glioblastoma; Phase I to begin next year
PRA Health Sciences acquires Symphony Health Solutions, scrip and prescriber data provider
Leading CRO looks to better trial recruitment, outcomes research
Post-approval trials of new drugs are showing limited clinical value
Is the accelerated-approval process providing a net benefit to patients?
Cold chain vendors enhance product and service lines
CEIV Pharma certification; expanded temperature regimes and better calibration capabilities
CVS readies a set of outcomes-based contracts for its clients
Oncology, obesity control and respiratory therapy are the first targets
Life Science Logistics expands warehouse capacity, again
Firm has quintupled its Indianapolis facility over two years
rfXcel gets a $30-million private equity boost
Pharma traceability company will expand global presence
FDA schedules public meetings for DSCSA
August, December and February meetings target unresolved technical issues
FDA struggles to react to ‘right to try’ laws
GAO report notes FDA’s 99% acceptance rate for ‘expanded access’, but legislators press on